Dimensional Fund Advisors
CRBU icon

Dimensional Fund Advisors’s Caribou Biosciences CRBU Stock Holding History

Dimensional Fund Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Sell
673,200
-332,810
-33% -$571K ﹤0.01% 2796
2025
Q4 		$1.6M Sell
1,006,010
-204,300
-17% -$429K ﹤0.01% 2774
2025
Q3 		$2.82M Sell
1,210,310
-97,045
-7% -$183K ﹤0.01% 2676
2025
Q2 		$1.65M Sell
1,307,355
-77,314
-6% -$76K ﹤0.01% 2810
2025
Q1 		$1.26M Sell
1,384,669
-347,709
-20% -$452K ﹤0.01% 2826
2024
Q4 		$2.75M Sell
1,732,378
-321,867
-16% -$647K ﹤0.01% 2709
2024
Q3 		$4.03M Sell
2,054,245
-569,038
-22% -$1.17M ﹤0.01% 2577
2024
Q2 		$4.3M Buy
2,623,283
+536,162
+26% +$1.71M ﹤0.01% 2538
2024
Q1 		$10.7M Buy
2,087,121
+736,337
+55% +$4.54M ﹤0.01% 2282
2023
Q4 		$7.74M Buy
1,350,784
+757,107
+128% +$3.74M ﹤0.01% 2423
2023
Q3 		$2.84M Buy
593,677
+462,997
+354% +$2.87M ﹤0.01% 2679
2023
Q2 		$555K Sell
130,680
-82,603
-39% -$371K ﹤0.01% 3042
2023
Q1 		$1.13M Buy
213,283
+91,478
+75% +$570K ﹤0.01% 2876
2022
Q4 		$765 Buy
+121,805
New +$1.08M ﹤0.01% 2965

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors's CRBU Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Caribou Biosciences (CRBU) stake by 33% in Q1 2026, selling an estimated $571K and leaving 673,200 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

Dimensional Fund Advisors first reported a position in CRBU in Q4 2022 and has held it in 14 quarters since. The position peaked at $10.7M in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Dimensional Fund Advisors held 673,200 shares of Caribou Biosciences worth $1.28M as of Q1 2026.
  • Dimensional Fund Advisors sold 332,810 Caribou Biosciences shares in Q1 2026, an estimated $571K.
  • Caribou Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2796 holding.
  • Dimensional Fund Advisors first reported a position in Caribou Biosciences in Q4 2022 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Caribou Biosciences position peaked at $10.7M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.